NDA 21-515
Wellbutrin (bupropion
hydrochloride)
Extended Release Tablets
GlaxoSmithKline, Inc
Sherita D. McLamore, Ph.D.
Division of Neuropharmacological
Drug Products
HFD-120
Back a Page
Next Page
Back to Wellbutrin XL NDA Index Page
Back to Main Index Page